Lee and Li Attorneys at Law | Taiwan | 1 Mar 2024
During the COVID-19 epidemic, the practice of medical diagnosis and treatment through telecommunications (i.e., via online clinics) became prevalent…
Lee Tsai & Partners | Taiwan | 28 Feb 2024
研究显示,不当饮食与生活型态为最主要的非传染病的致因。为有效预防及控制非传染病,世界卫生组织(World Health Organization)于2013年发布…
Lee Tsai & Partners | Taiwan | 16 Feb 2024
研究顯示,不當飲食與生活型態為最主要的非傳染病的致因。為有效預防及控制非傳染病,世界衛生組織(World Health Organization)於2013年發布…
Lee Tsai & Partners | Taiwan | 8 Feb 2024
Research consistently indicates that inadequate diet and improper lifestyle are the primary contributors to noncommunicable…
In-Depth
PRO
Editor:
Peter Bogaert
Covington & Burling LLP
In-Depth: Life Sciences Law (formerly The Life Sciences Law Review) is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology and medical device companies in key jurisdictions worldwide. It covers the major rules and restrictions throughout the life cycle of regulated products, from discovery to clinical trials, the marketing authorisation process and post-approval controls. It also examines the most consequential recent trends and developments in the sector.
Lee Tsai & Partners | Taiwan | 30 Jan 2024
2023年为台湾生技医药领域发生重大变革之一年。「医疗事故预防及争议处理法」的即将实施,凸显了我国对医疗品质与患者权益的重视。同时,「次世代基因定序检测」…
Lee Tsai & Partners | Taiwan | 30 Jan 2024
2023年為臺灣生技醫藥領域發生重大變革之一年。「醫療事故預防及爭議處理法」的即將實施,凸顯了我國對醫療品質與患者權益的重視。同時,…
Lee Tsai & Partners | Taiwan | 30 Jan 2024
In 2023, Taiwan witnessed significant transformations in the field of biomedicine. The imminent implementation of the “ Medical Accident Prevention…